Merck & Co., Inc.RAhway, New Jersey, United States
Disclosure(s): Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA (MSD): Employee, Stocks/Bonds (Public Company)
167 - Phase 3, Randomized, Controlled Trial Evaluating Safety, Efficacy, and Pharmacokinetics (PK) of Clesrovimab in Infants and Children at Increased Risk for Severe Respiratory Syncytial Virus (RSV) Disease
Thursday, October 17, 20242:21 PM – 2:33 PM US PT
